# Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis

> **NCT01355796** · PHASE1,PHASE2 · COMPLETED · sponsor: **Joseph Zabner** · enrollment: 30 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Xylitol
- **DRUG:** Hypertonic saline

## Key facts

- **NCT ID:** NCT01355796
- **Lead sponsor:** Joseph Zabner
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355796, "Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01355796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*